摘要
目的探讨应用丁二磺酸腺苷蛋氨酸肠溶片联合复方甘草酸苷治疗酒精性肝硬化患者的疗效及其对血清骨钙素(BGP)水平的影响。方法2016年3月~2018年2月我院诊治的酒精性肝硬化患者276例,采用随机数字表法分为观察组(n=138)和对照组(n=138)。给予对照组患者丁二磺酸腺苷蛋氨酸肠溶片口服,观察组患者在对照组治疗的基础上给予复方甘草酸苷注射液静脉滴注,治疗3 w。采用放射免疫法检测血清BGP水平,采用ELISA法检测血清胰岛素样生长因子1(IGF-1)水平,采用化学发光免疫法检测血清透明质酸(HA)、黏连蛋白(LN)、IV型胶原(IV-C)和III型前胶原(PC-III)水平。结果在治疗结束时,观察组血清ALB为(36.8±10.3)g/L,显著高于对照组[(29.4±9.2)g/L,P<0.05],血清TBIL为(26.4±5.1)μmol/L,显著低于对照组[(47.3±9.4)μmol/L,P<0.05],血清GGT水平为(158.6±72.8)U/L,显著低于对照组[(254.6±100.4)U/L,P<0.05];观察组血清HA为(72.6±18.4)μg/L,显著低于对照组[(158.4±30.5)μg/L,P<0.05],LN为(87.4±8.3)μg/L,显著低于对照组[(165.3±19.8)μg/L,P<0.05],PC-III为(94.5±31.3)μg/L,显著低于对照组[(147.4±42.5)μg/L,P<0.05],IV-C为(64.3±9.5)μg/L,显著低于对照组[(98.4±26.4)μg/L,P<0.05];观察组血清IGF-1水平为(198.2±34.6)ng/ml,显著高于对照组[(162.5±30.5)ng/ml,P<0.05],BGP为(8.8±3.9)ng/ml,显著高于对照组[(6.7±3.0)ng/ml,P<0.05]。结论应用丁二磺酸腺苷蛋氨酸肠溶片联合复方甘草酸苷治疗酒精性肝硬化患者近期疗效显著,可显著改善患者肝功能指标,可能与升高了血清IGF-1和BGP水平有关。
Objective The purpose of this study to investigate the efficacy of adenosine methionine and glycyrrhizin combination in the treatment of patients with alcoholic cirrhosis and its effect on serum osteocalcin(BGP)levels.Methods A total of 276 patients with alcoholic cirrhosis were recruited in our hospital between March 2016 and February 2018,and were randomly divided into observation group(n=138)and control group(n=138).The patients in the control group were given adenosine methionine enteric-coated tablets,and the patients in the observation were given an intravenous infusion of compound glycyrrhizin at the base of adenosine methionine administration for three weeks.Serum BGP levels were assayed by radioimmunoassay and serum IGF-1 levels were detected by enzyme-linked immunosorbent assay.Serum f hyaluronic acid(HA),laminin(LN),type IV collagen(IV-C)and type III procollagen(PCIII)were detected by chemiluminescence immunoassay.Results Serum albumin level in the observation group was(36.8±10.3)g/L,significantly higher than[(29.4±9.2)g/L,P<0.05]in the control group,serum bilirumin level was(26.4±5.1)μmol/L,significantly lower than[(47.3±9.4)μmol/L,P<0.05]in the control group,and serum GGT level was(158.6±72.8)U/L,significantly lower than[(254.6±100.4)U/L,P<0.05]in the control group;serum HA level in the observation group was(72.6±18.4)μg/L,significantly lower than[(158.4±30.5)μg/L,P<0.05]in the control,serum LN level was(87.4±8.3)μg/L,significantly lower than[(165.3±19.8)μg/L,P<0.05]in the control,serum PCIII level was(94.5±31.3)μg/L,significantly lower than[(147.4±42.5)μg/L,P<0.05]in the control,and serum IV-C level was(64.3±9.5)μg/L,significantly lower than[(98.4±26.4)μg/L,P<0.05]in the control;serum IGF-1 level in the observation group was(198.2±34.6)ng/ml,significantly higher than[(162.5±30.5)ng/ml,P<0.05]in the control,and serum BGP level was(8.8±3.9)ng/ml,significantly higher than[(6.7±3.0)ng/ml,P<0.05]in the control group.Conclusion Application of adenosine methionine and glycyrrhizin is efficacious in the treatment of patients with alcoholic cirrhosis,which can effectively improve liver function tests,and significantly increase serum IGF-1 and BGP levels.
作者
朱娅鸽
刘锦峰
Zhu Yage;Liu Jinfeng(Department of Infectious Diseases,First Affiliated Hospital,Medical College,Jiaotong University,Xian 710061,Shaanxi Provinc,China)
出处
《实用肝脏病杂志》
CAS
2019年第6期872-875,共4页
Journal of Practical Hepatology
基金
陕西省创新能力支撑计划基金资助项目(编号:2018KRM092)
